Artemis Institute for Clinical Research

What Artemis Institute for Clinical Research does

Artemis Institute for Clinical Research is a privately held clinical research site organization founded in 2008 and headquartered in San Diego, California, with a secondary site in Riverside, California, and a corporate office in Atlantis, Florida. Acquired by Headlands Research in February 2021, Artemis operates as a Headlands Research site while retaining its own brand identity. The firm executes Phase 1 through Phase IV clinical trials on behalf of pharmaceutical, biotechnology, and medical device sponsors, covering more than a dozen therapeutic areas including CNS indications (Alzheimer's, anxiety, depression, insomnia, schizophrenia), cardiometabolic disease (ASCVD, weight loss/obesity, liver disease), pain (back pain, diabetic neuropathic pain, osteoarthritis), and vaccine research. Named sponsor engagements include Teva (TV46000 RISE schizophrenia trial), Eisai (DayVigo/lemborexant FDA approval), and Idorsia (daridorexant Phase 3 in insomnia).

The company's core product is its Phase 1 Research Unit, opened in 2017 and operational 24/7, comprising 12 beds (4 private), an on-site investigational pharmacy, dedicated lab, enclosed nursing station, participant lounge, dining area, and three polysomnographic (sleep-testing) rooms. Supporting offerings include telehealth-based pre-screening, a refer-a-friend recruitment program offering up to a $100 gift card, and Lyft-based transportation for participants. Artemis draws from a database of over 75,000 participants spanning Southern California communities and more than four major universities, supporting diverse enrollment by ethnicity and age. Over the company's history it has completed more than 315 successful trials and enrolled more than 15,000 participants, earning the PharmaTimes Clinical Site Team / Clinical Site of the Year award in 2018 (for The Americas) and 2020.

Artemis is paid on a professional-services, fee-for-service basis by trial sponsors for protocol execution, patient recruitment, data collection, physician oversight, and regulatory compliance, working under independent IRB oversight. Patient recruitment runs through a multi-channel GTM: a dedicated 1-855-DOSTUDIES phone line, English/Spanish web sign-up, paid digital and traditional advertising (billboard, bus stop, radio, TV), social media, and community referrals. Pricing to sponsors is contractually negotiated and not publicly disclosed; participants receive financial compensation for time and travel and free study-related medical evaluations, with no insurance required.

Name

Artemis Institute for Clinical Research

Legal name

Artemis Institute for Clinical Research

Website

https://artemis-research.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Artemis Institute for Clinical Research is a San Diego-based clinical research site organization that conducts Phase 1–IV trials across 12+ therapeutic areas for pharmaceutical and biotech sponsors. Founded in 2008 and acquired by Headlands Research in 2021, it has completed 315+ trials enrolling 15,000+ participants.

Ownership category

akta.pro rank

Product category

Clinical Research Site Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

• Clinical trial services
• Phase 1 clinical research
• Polysomnographic sleep testing
• Clinical research site network
• Biopharmaceutical contract research

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Clinical Trial Sponsorship Fees: Artemis conducts clinical trials on behalf of study sponsors, which are typically pharmaceutical companies, medical device companies, or biotech firms. Artemis is hired to execute trials according to sponsor-defined protocols, including patient recruitment, data collection, physician oversight, and regulatory compliance. Revenue is derived from contractual agreements with these sponsors for the execution of clinical research.
2. IRB Review Services: Clinical trial protocols are reviewed by an independent institutional review board (IRB) made up of physicians, researchers, and community members. Artemis works within this regulatory framework as part of its service model.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Artemis Institute for Clinical Research is a clinical research site organization that executes sponsored clinical trials on behalf of pharmaceutical, biotech, and medical device companies. It recruits, screens, and manages participants across 12+ therapeutic areas at its San Diego and Riverside, California facilities, including a 24/7 dedicated Phase 1 research unit with investigational pharmacy, polysomnographic sleep testing, and telehealth/virtual trial capabilities. Trial participants receive financial compensation for time and travel, no-cost study-related medical care, and the investigative medication or device at no charge.

Product overview

Artemis Institute for Clinical Research is a clinical research site organization founded in 2008, acquired by Headlands Research in 2021, offering a unified platform of clinical trial services. The core offering consists of Clinical Trial Services conducting trials across 12+ therapeutic areas (Alcohol & Drug Abuse, Alzheimer's Disease, Anxiety Disorder, Atherosclerotic Cardiovascular Disease, Back Pain, Depression, Diabetic Neuropathic Pain, Healthy Volunteer, Liver Disease, Obstructive Sleep Apnea, Osteoarthritis, Vaccine, Weight Loss & Obesity), supported by a Phase 1 Research Unit operational since 2017 with 12 beds and specialized sleep testing capabilities. Additional services include a Refer a Friend incentive program and Telehealth Prescreen Services for virtual eligibility assessment. The organization has conducted over 315 successful trials with more than 15,000 trial participants across its two Southern California locations in San Diego and Riverside.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services Full-service clinical trial execution for sponsor companies, including patient recruitment, screening, telehealth prescreen visits, in-person office visits, dosing, data collection, and ongoing participant support throughout the trial duration across multiple therapeutic areas.
• Phase 1 Research Unit Dedicated Phase 1 clinical research unit operating 24/7 with 12 beds (including 4 private rooms), 3 polysomnographic sleep-testing rooms, an investigational pharmacy, lab, enclosed nursing station, dining services, and a participant recreation specialist, available to sponsors for early-phase and sleep-disorder trials.
• Telehealth Prescreen Services Virtual prescreen visits with medical professionals to review medical history and study details before scheduling in-person screening, enabling virtual trial participation for eligible candidates.
• Lyft Transportation Service for Participants Lyft-based transportation service provided to participants who lack independent transportation to and from Artemis's San Diego and Riverside study sites.

Quantifiable outcome

• 315+ successful trials conducted
• +5 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Headlands ResearchflagshipOthers · 17 February 2021Headlands Research, a global next-generation clinical research site organization, acquired Artemis Institute for Clinical Research in February 2021. The acquisition significantly strengthened Headlands' position in Southern California. Artemis Institute is now a Headlands Research site, operating under the parent company's site network while maintaining its own brand identity. Artemis benefits from Headlands' scale, capabilities, and resources while continuing to serve its participant and sponsor base.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Largest global CRO with broad CNS and Phase 1 capabilities through dedicated site networks. Comparable as the dominant incumbent that controls significant sponsor protocol allocation decisions.
• ICON plc: Global CRO with dedicated early-phase and CNS franchises post-PRA integration. Comparable as a broad incumbent competing for the same pharma sponsor trials Artemis services.
• Medpace: Full-service CRO with established CNS franchise and dedicated site relationships. Comparable as a competing channel through which Artemis could be engaged as a preferred site for sponsor trials.

Direct peers

• Velocity Clinical Research: Multi-site integrated clinical research site organization acquired by Kohlberg & Company. Directly comparable as a scaled SMO competitor for sponsor placement and CNS trial execution.
• Celerion: Specialized early-phase clinical research organization with dedicated Phase 1 units and bioanalytical labs. Directly comparable on Artemis's Phase 1 Research Unit and polysomnographic sleep capabilities.
• Worldwide Clinical Trials: Mid-size CRO with strong CNS and early-phase capabilities. Directly comparable as a CNS-focused clinical trial execution competitor with Phase 1 expertise.
• Headlands Research: Parent site network operating multi-therapeutic clinical research sites in North America. Directly comparable as Artemis's parent organization and site-network peer operating under a similar SMO model.
• Accel Research Sites: Multi-therapeutic SMO network across the US Southeast and beyond. Comparable as a direct community-site competitor pursuing similar sponsor placement and trial execution strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/artemisresearch
• YouTubeyoutube.com/channel/UCHzJpEu7SuU1Gg5YdgqSKSg
• Facebookfacebook.com/ArtemisInstitute
• LinkedInlinkedin.com/company/artemis-research
• Instagraminstagram.com/artemisinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artemis Institute for Clinical Research